Healthcare

Novartis Phase III Trials Show Ianalumab Significantly Improves Outcomes in Sjögren’s Disease

(IN BRIEF) Novartis has reported landmark Phase III results showing that ianalumab significantly reduced disease activity in patients with Sjögren’s…

2 months ago

SCHOTT Pharma Sets New Standard with ISO-Compliant Ready-to-Use Polymer Cartridge for Biologics

IN BRIEF) SCHOTT Pharma has introduced the SCHOTT TOPPAC® cartridge, the first ready-to-use polymer cartridge to meet ISO dimensions, offering…

2 months ago

Amolf Scientist Wins ZonMW Off Road Grant to Unravel Immune System’s Molecular Brakes

(IN BRIEF) Amolf researcher Megan Farrell has received the Off Road grant from ZonMW to study how the immune system’s…

2 months ago

New Isotope Fingerprinting Technique Flags Counterfeit Medicines by Factory Origin

(IN BRIEF) A collaborative study by the University of Copenhagen and Stanford University has revealed that pharmaceuticals possess unique isotopic…

2 months ago

Almirall and Absci Advance AI Drug Discovery with Second Dermatology Target Selection

(IN BRIEF) Almirall and Absci have expanded their AI-based drug discovery collaboration by selecting a second dermatological target, following the…

2 months ago

Glasgow Chemists Harness Dual-Frequency Ultrasound to Mineralize BPA in Water

(IN BRIEF) Researchers at the University of Glasgow’s School of Chemistry have developed a novel, catalyst-free ultrasound method to destroy…

2 months ago

Fresenius Kabi Secures Global Rights to PB016 Vedolizumab Biosimilar from Polpharma Biologics

(IN BRIEF) Fresenius Kabi has licensed rights from Polpharma Biologics to commercialize the vedolizumab biosimilar candidate PB016 globally—except in the…

2 months ago